Systemic inflammation as a risk factor for atherothrombosis.

Area of Science:

• Immunology
• Cardiology
• Infectious Diseases

Background:

• Chronic inflammatory disorders, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), are linked to higher cardiovascular disease (CVD) rates.
• Chronic infections with an inflammatory component, such as human immunodeficiency virus (HIV), also elevate CVD risk.
• Cardiovascular mortality is a significant cause of death in patients with these conditions.

Purpose of the Study:

• To highlight the link between systemic inflammation and cardiovascular disease.
• To emphasize the early onset of atherothrombotic processes in chronic inflammatory states.
• To advocate for early cardiovascular protection strategies in at-risk patient populations.

Main Methods:

• Review of existing literature on chronic inflammation and cardiovascular disease.
• Analysis of pathophysiological mechanisms linking inflammation to atherogenesis.
• Examination of the pre-clinical phase of cardiovascular disease development.

Main Results:

• Systemic inflammation directly and indirectly promotes atherothrombotic vascular disease.
• Atherogenesis can begin years before the clinical diagnosis of chronic inflammatory diseases.
• Widespread risk factor exposure occurs during the pre-clinical phase.

Conclusions:

• Patients with chronic inflammatory disorders and infections face elevated CVD risk.
• Early intervention is necessary to mitigate cardiovascular risks associated with systemic inflammation.
• Proactive cardiovascular protection strategies are warranted in individuals predisposed to inflammation-driven vascular disease.